Prospective Translational Study Investigating Predictors of Outcome in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab (I-Rene Trial)
Latest Information Update: 08 Dec 2023
At a glance
- Drugs Cabozantinib (Primary) ; Nivolumab (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- Acronyms I-Rene; Meet-URO 8 study
- 24 Oct 2023 Results assessing potential of measuring dynamic changes occurring in peripheral blood as indicators of response to NIVO in mRCC pts presented at the 48th European Society for Medical Oncology Congress
- 24 Oct 2023 Status changed from recruiting to completed according to results presented at the 48th European Society for Medical Oncology Congress.
- 18 Feb 2023 Results (n=82) presented at the 2023 Genitourinary Cancers Symposium